The New South Wales Drug Summit: a view from a local foreign observer

---

• 1.
• Swan N. Drug doings down under. JAMA 1999; 281: 1782-1783.
• 2.
• Samet JH, Rollnick S, Barnes H. Beyond CAGE: a brief clinical approach after detection of substance abuse. Arch Intern Med 1996; 156: 2287-2293.
• 3.
• Musto D. The American disease: origins of narcotic control. New York: Oxford University Press, 1987.
• 4.
• Centers for Disease Control and Prevention. HIV/AIDS surveillance report. 1997; 9(2): 1-44.
• 5.
• Kaldor JM, Elford J, Wodak AD, et al. HIV prevalence among IDUs in Australia: a methodological review. Drug Alcohol Rev 1993; 12: 175-184.
• 6.
• MacDonald M, Wodak AD, Ali R, et al. HIV prevalence and risk behaviour in needle exchange attenders: a national study. Med J Aust 1997; 166: 237-240.
• 7.
• Darke S, Ross J, Hall W. Overdose among heroin users in Sydney, Australia I. Prevalence and correlates of non-fatal overdose. Addiction 1996; 91: 405-411.
• 8.
• Darke S, Ross J, Hall W. Overdose among heroin users in Sydney, Australia I. Responses to overdose. Addiction 1996; 91: 413-417.
• 9.
• Hurley SF, Jolley DJ, Kaldor JM. Effectiveness of needle-exchange programmes for prevention of HIV infection. Lancet 1997; 349: 1797-1800.
• 10.
• Drucker E, Lurie P, Wodak A, Alcabes P. Measuring harm reduction: the effects of needle and syringe exchange programs and methadone maintenance on the ecology of HIV. AIDS 1998; 12(Suppl A): S217-S230.